CONMED Corporation (NYSE: CNMD) Stock Competitors & Peer Comparison
See CNMD's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for CNMD and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CNMD | $49.29 | -1.06% | 1.5B | 11.09 | $4.55 | +0.40% |
| ABT | $110.37 | -0.81% | 192.5B | 21.35 | $5.21 | +2.23% |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| SYK | $336.20 | -1.43% | 129.8B | 25.29 | $13.39 | +1.02% |
| MDT | $91.15 | +0.63% | 116.8B | 16.50 | $5.53 | +3.11% |
| BSX | $51.59 | -0.20% | 77B | 16.72 | $3.10 | N/A |
| EW | $90.81 | -1.89% | 52.7B | 33.93 | $2.70 | N/A |
| DXCM | $88.57 | -2.46% | 34.5B | 39.26 | $2.33 | N/A |
| RMD | $220.33 | -2.83% | 32.6B | 20.84 | $10.77 | +1.07% |
| PHG | $26.96 | -1.55% | 26.7B | 15.59 | $1.75 | +3.62% |
Stock Comparison
Abbott Laboratories (NYSE: ABT)
CNMD vs ABT Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, ABT has a market cap of 192.5B. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while ABT trades at $110.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas ABT's P/E ratio is 21.35. In terms of profitability, CNMD's ROE is +0.06%, compared to ABT's ROE of +0.11%. Regarding short-term risk, CNMD is less volatile compared to ABT. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check ABT's competition here
Boston Scientific Corporation (NYSE: BSX-PA)
CNMD vs BSX-PA Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, CNMD's ROE is +0.06%, compared to BSX-PA's ROE of +0.15%. Regarding short-term risk, CNMD is less volatile compared to BSX-PA. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check BSX-PA's competition here
Stryker Corporation (NYSE: SYK)
CNMD vs SYK Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, SYK has a market cap of 129.8B. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while SYK trades at $336.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas SYK's P/E ratio is 25.29. In terms of profitability, CNMD's ROE is +0.06%, compared to SYK's ROE of +0.16%. Regarding short-term risk, CNMD is more volatile compared to SYK. This indicates higher risk in terms of short-term price fluctuations for CNMD.Check SYK's competition here
Medtronic plc (NYSE: MDT)
CNMD vs MDT Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, MDT has a market cap of 116.8B. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while MDT trades at $91.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas MDT's P/E ratio is 16.50. In terms of profitability, CNMD's ROE is +0.06%, compared to MDT's ROE of +0.10%. Regarding short-term risk, CNMD is less volatile compared to MDT. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check MDT's competition here
Boston Scientific Corporation (NYSE: BSX)
CNMD vs BSX Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, BSX has a market cap of 77B. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while BSX trades at $51.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas BSX's P/E ratio is 16.72. In terms of profitability, CNMD's ROE is +0.06%, compared to BSX's ROE of +0.15%. Regarding short-term risk, CNMD is less volatile compared to BSX. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check BSX's competition here
Edwards Lifesciences Corporation (NYSE: EW)
CNMD vs EW Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, EW has a market cap of 52.7B. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while EW trades at $90.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas EW's P/E ratio is 33.93. In terms of profitability, CNMD's ROE is +0.06%, compared to EW's ROE of +0.10%. Regarding short-term risk, CNMD is more volatile compared to EW. This indicates higher risk in terms of short-term price fluctuations for CNMD.Check EW's competition here
DexCom, Inc. (NASDAQ: DXCM)
CNMD vs DXCM Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, DXCM has a market cap of 34.5B. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while DXCM trades at $88.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas DXCM's P/E ratio is 39.26. In terms of profitability, CNMD's ROE is +0.06%, compared to DXCM's ROE of +0.36%. Regarding short-term risk, CNMD is less volatile compared to DXCM. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check DXCM's competition here
ResMed Inc. (NYSE: RMD)
CNMD vs RMD Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, RMD has a market cap of 32.6B. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while RMD trades at $220.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas RMD's P/E ratio is 20.84. In terms of profitability, CNMD's ROE is +0.06%, compared to RMD's ROE of +0.24%. Regarding short-term risk, CNMD is less volatile compared to RMD. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check RMD's competition here
Koninklijke Philips N.V. (NYSE: PHG)
CNMD vs PHG Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, PHG has a market cap of 26.7B. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while PHG trades at $26.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas PHG's P/E ratio is 15.59. In terms of profitability, CNMD's ROE is +0.06%, compared to PHG's ROE of +0.10%. Regarding short-term risk, CNMD is more volatile compared to PHG. This indicates higher risk in terms of short-term price fluctuations for CNMD.Check PHG's competition here
Zimmer Biomet Holdings, Inc. (NYSE: ZBH)
CNMD vs ZBH Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, ZBH has a market cap of 19.5B. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while ZBH trades at $98.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas ZBH's P/E ratio is 11.87. In terms of profitability, CNMD's ROE is +0.06%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, CNMD is less volatile compared to ZBH. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check ZBH's competition here
Abiomed, Inc. (NASDAQ: ABMD)
CNMD vs ABMD Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas ABMD's P/E ratio is 65.36. In terms of profitability, CNMD's ROE is +0.06%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, CNMD is more volatile compared to ABMD. This indicates higher risk in terms of short-term price fluctuations for CNMD.Check ABMD's competition here
Align Technology, Inc. (NASDAQ: ALGN)
CNMD vs ALGN Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, ALGN has a market cap of 13B. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while ALGN trades at $173.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas ALGN's P/E ratio is 16.53. In terms of profitability, CNMD's ROE is +0.06%, compared to ALGN's ROE of +0.10%. Regarding short-term risk, CNMD is less volatile compared to ALGN. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check ALGN's competition here
Penumbra, Inc. (NYSE: PEN)
CNMD vs PEN Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, PEN has a market cap of 12.9B. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while PEN trades at $327.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas PEN's P/E ratio is 85.38. In terms of profitability, CNMD's ROE is +0.06%, compared to PEN's ROE of +0.11%. Regarding short-term risk, CNMD is more volatile compared to PEN. This indicates higher risk in terms of short-term price fluctuations for CNMD.Check PEN's competition here
ShockWave Medical, Inc. (NASDAQ: SWAV)
CNMD vs SWAV Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas SWAV's P/E ratio is 78.76. In terms of profitability, CNMD's ROE is +0.06%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, CNMD is more volatile compared to SWAV. This indicates higher risk in terms of short-term price fluctuations for CNMD.Check SWAV's competition here
Smith & Nephew plc (NYSE: SNN)
CNMD vs SNN Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, SNN has a market cap of 12.5B. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while SNN trades at $29.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas SNN's P/E ratio is 14.04. In terms of profitability, CNMD's ROE is +0.06%, compared to SNN's ROE of +0.12%. Regarding short-term risk, CNMD is more volatile compared to SNN. This indicates higher risk in terms of short-term price fluctuations for CNMD.Check SNN's competition here
Globus Medical, Inc. (NYSE: GMED)
CNMD vs GMED Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, GMED has a market cap of 11.6B. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while GMED trades at $84.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas GMED's P/E ratio is 19.35. In terms of profitability, CNMD's ROE is +0.06%, compared to GMED's ROE of +0.12%. Regarding short-term risk, CNMD is more volatile compared to GMED. This indicates higher risk in terms of short-term price fluctuations for CNMD.Check GMED's competition here
Glaukos Corporation (NYSE: GKOS)
CNMD vs GKOS Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, GKOS has a market cap of 10.9B. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while GKOS trades at $185.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas GKOS's P/E ratio is -214.53. In terms of profitability, CNMD's ROE is +0.06%, compared to GKOS's ROE of -0.27%. Regarding short-term risk, CNMD is less volatile compared to GKOS. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check GKOS's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO-B)
CNMD vs BIO-B Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, BIO-B has a market cap of 10.1B. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while BIO-B trades at $368.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas BIO-B's P/E ratio is 109.45. In terms of profitability, CNMD's ROE is +0.06%, compared to BIO-B's ROE of +0.03%. Regarding short-term risk, CNMD is more volatile compared to BIO-B. This indicates higher risk in terms of short-term price fluctuations for CNMD.Check BIO-B's competition here
Insulet Corp. (NASDAQ: PODD)
CNMD vs PODD Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, PODD has a market cap of 9.9B. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while PODD trades at $140.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas PODD's P/E ratio is 24.42. In terms of profitability, CNMD's ROE is +0.06%, compared to PODD's ROE of +0.27%. Regarding short-term risk, CNMD is less volatile compared to PODD. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check PODD's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO)
CNMD vs BIO Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, BIO has a market cap of 9.6B. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while BIO trades at $356.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas BIO's P/E ratio is 38.41. In terms of profitability, CNMD's ROE is +0.06%, compared to BIO's ROE of +0.03%. Regarding short-term risk, CNMD is more volatile compared to BIO. This indicates higher risk in terms of short-term price fluctuations for CNMD.Check BIO's competition here
Masimo Corporation (NASDAQ: MASI)
CNMD vs MASI Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while MASI trades at $179.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas MASI's P/E ratio is 44.43. In terms of profitability, CNMD's ROE is +0.06%, compared to MASI's ROE of +0.09%. Regarding short-term risk, CNMD is more volatile compared to MASI. This indicates higher risk in terms of short-term price fluctuations for CNMD.Check MASI's competition here
Bruker Corporation (NASDAQ: BRKR)
CNMD vs BRKR Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, BRKR has a market cap of 8.8B. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while BRKR trades at $57.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas BRKR's P/E ratio is 28.99. In terms of profitability, CNMD's ROE is +0.06%, compared to BRKR's ROE of -0.03%. Regarding short-term risk, CNMD is less volatile compared to BRKR. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check BRKR's competition here
Inari Medical, Inc. (NASDAQ: NARI)
CNMD vs NARI Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas NARI's P/E ratio is -59.24. In terms of profitability, CNMD's ROE is +0.06%, compared to NARI's ROE of -0.00%. Regarding short-term risk, CNMD is more volatile compared to NARI. This indicates higher risk in terms of short-term price fluctuations for CNMD.Check NARI's competition here
LivaNova PLC (NASDAQ: LIVN)
CNMD vs LIVN Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, LIVN has a market cap of 4.5B. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while LIVN trades at $81.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas LIVN's P/E ratio is 19.53. In terms of profitability, CNMD's ROE is +0.06%, compared to LIVN's ROE of +0.15%. Regarding short-term risk, CNMD is more volatile compared to LIVN. This indicates higher risk in terms of short-term price fluctuations for CNMD.Check LIVN's competition here
Integer Holdings Corporation (NYSE: ITGR)
CNMD vs ITGR Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, ITGR has a market cap of 4.3B. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while ITGR trades at $125.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas ITGR's P/E ratio is 19.73. In terms of profitability, CNMD's ROE is +0.06%, compared to ITGR's ROE of +0.07%. Regarding short-term risk, CNMD is more volatile compared to ITGR. This indicates higher risk in terms of short-term price fluctuations for CNMD.Check ITGR's competition here
iRhythm Technologies, Inc. (NASDAQ: IRTC)
CNMD vs IRTC Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, IRTC has a market cap of 4.2B. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while IRTC trades at $117.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas IRTC's P/E ratio is -197.56. In terms of profitability, CNMD's ROE is +0.06%, compared to IRTC's ROE of -0.09%. Regarding short-term risk, CNMD is less volatile compared to IRTC. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check IRTC's competition here
Haemonetics Corporation (NYSE: HAE)
CNMD vs HAE Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, HAE has a market cap of 4.1B. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while HAE trades at $90.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas HAE's P/E ratio is 18.14. In terms of profitability, CNMD's ROE is +0.06%, compared to HAE's ROE of +0.11%. Regarding short-term risk, CNMD is less volatile compared to HAE. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check HAE's competition here
Axonics, Inc. (NASDAQ: AXNX)
CNMD vs AXNX Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas AXNX's P/E ratio is -709.80. In terms of profitability, CNMD's ROE is +0.06%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, CNMD is more volatile compared to AXNX. This indicates higher risk in terms of short-term price fluctuations for CNMD.Check AXNX's competition here
TransMedics Group, Inc. (NASDAQ: TMDX)
CNMD vs TMDX Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, TMDX has a market cap of 3.1B. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while TMDX trades at $87.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas TMDX's P/E ratio is 44.96. In terms of profitability, CNMD's ROE is +0.06%, compared to TMDX's ROE of +0.33%. Regarding short-term risk, CNMD is less volatile compared to TMDX. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check TMDX's competition here
AxoGen, Inc. (NASDAQ: AXGN)
CNMD vs AXGN Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, AXGN has a market cap of 2.6B. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while AXGN trades at $48.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas AXGN's P/E ratio is 128.24. In terms of profitability, CNMD's ROE is +0.06%, compared to AXGN's ROE of -0.18%. Regarding short-term risk, CNMD is less volatile compared to AXGN. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check AXGN's competition here
UFP Technologies, Inc. (NASDAQ: UFPT)
CNMD vs UFPT Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, UFPT has a market cap of 2.5B. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while UFPT trades at $320.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas UFPT's P/E ratio is 32.87. In terms of profitability, CNMD's ROE is +0.06%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, CNMD is more volatile compared to UFPT. This indicates higher risk in terms of short-term price fluctuations for CNMD.Check UFPT's competition here
Butterfly Network, Inc. (NYSE: BFLY)
CNMD vs BFLY Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, BFLY has a market cap of 2.4B. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while BFLY trades at $8.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas BFLY's P/E ratio is -36.79. In terms of profitability, CNMD's ROE is +0.06%, compared to BFLY's ROE of -0.38%. Regarding short-term risk, CNMD is less volatile compared to BFLY. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check BFLY's competition here
Establishment Labs Holdings Inc. (NASDAQ: ESTA)
CNMD vs ESTA Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, ESTA has a market cap of 2.3B. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while ESTA trades at $75.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas ESTA's P/E ratio is -63.07. In terms of profitability, CNMD's ROE is +0.06%, compared to ESTA's ROE of -2.04%. Regarding short-term risk, CNMD is less volatile compared to ESTA. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check ESTA's competition here
NuVasive, Inc. (NASDAQ: NUVA)
CNMD vs NUVA Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas NUVA's P/E ratio is 75.00. In terms of profitability, CNMD's ROE is +0.06%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, CNMD is less volatile compared to NUVA. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check NUVA's competition here
Novocure Ltd (NASDAQ: NVCR)
CNMD vs NVCR Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, NVCR has a market cap of 2B. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while NVCR trades at $17.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas NVCR's P/E ratio is -11.08. In terms of profitability, CNMD's ROE is +0.06%, compared to NVCR's ROE of -0.44%. Regarding short-term risk, CNMD is less volatile compared to NVCR. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check NVCR's competition here
Inspire Medical Systems, Inc. (NYSE: INSP)
CNMD vs INSP Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, INSP has a market cap of 1.6B. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while INSP trades at $56.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas INSP's P/E ratio is 25.13. In terms of profitability, CNMD's ROE is +0.06%, compared to INSP's ROE of +0.18%. Regarding short-term risk, CNMD is less volatile compared to INSP. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check INSP's competition here
Tandem Diabetes Care, Inc. (NASDAQ: TNDM)
CNMD vs TNDM Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, TNDM has a market cap of 1.6B. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while TNDM trades at $22.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas TNDM's P/E ratio is -20.65. In terms of profitability, CNMD's ROE is +0.06%, compared to TNDM's ROE of -0.46%. Regarding short-term risk, CNMD is less volatile compared to TNDM. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check TNDM's competition here
Alphatec Holdings, Inc. (NASDAQ: ATEC)
CNMD vs ATEC Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, ATEC has a market cap of 1.5B. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while ATEC trades at $9.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas ATEC's P/E ratio is -163.17. In terms of profitability, CNMD's ROE is +0.06%, compared to ATEC's ROE of -8.19%. Regarding short-term risk, CNMD is less volatile compared to ATEC. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check ATEC's competition here
Enovis Corporation (NYSE: ENOV)
CNMD vs ENOV Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, ENOV has a market cap of 1.5B. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while ENOV trades at $24.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas ENOV's P/E ratio is 7.47. In terms of profitability, CNMD's ROE is +0.06%, compared to ENOV's ROE of -0.68%. Regarding short-term risk, CNMD is less volatile compared to ENOV. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check ENOV's competition here
Integra LifeSciences Holdings Corporation (NASDAQ: IART)
CNMD vs IART Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, IART has a market cap of 1.4B. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while IART trades at $17.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas IART's P/E ratio is 7.77. In terms of profitability, CNMD's ROE is +0.06%, compared to IART's ROE of -0.01%. Regarding short-term risk, CNMD is less volatile compared to IART. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check IART's competition here
Artivion, Inc. (NYSE: AORT)
CNMD vs AORT Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, AORT has a market cap of 1.4B. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while AORT trades at $28.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas AORT's P/E ratio is 48.60. In terms of profitability, CNMD's ROE is +0.06%, compared to AORT's ROE of -0.01%. Regarding short-term risk, CNMD is less volatile compared to AORT. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check AORT's competition here
Heska Corporation (NASDAQ: HSKA)
CNMD vs HSKA Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas HSKA's P/E ratio is -62.49. In terms of profitability, CNMD's ROE is +0.06%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, CNMD is more volatile compared to HSKA. This indicates higher risk in terms of short-term price fluctuations for CNMD.Check HSKA's competition here
PROCEPT BioRobotics Corporation (NASDAQ: PRCT)
CNMD vs PRCT Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, PRCT has a market cap of 1.2B. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while PRCT trades at $20.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas PRCT's P/E ratio is -11.16. In terms of profitability, CNMD's ROE is +0.06%, compared to PRCT's ROE of -0.31%. Regarding short-term risk, CNMD is less volatile compared to PRCT. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check PRCT's competition here
Avanos Medical, Inc. (NYSE: AVNS)
CNMD vs AVNS Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while AVNS trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas AVNS's P/E ratio is 27.77. In terms of profitability, CNMD's ROE is +0.06%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, CNMD is more volatile compared to AVNS. This indicates higher risk in terms of short-term price fluctuations for CNMD.Check AVNS's competition here
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI)
CNMD vs LMRI Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, LMRI has a market cap of 1.2B. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while LMRI trades at $12.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas LMRI's P/E ratio is -23.39. In terms of profitability, CNMD's ROE is +0.06%, compared to LMRI's ROE of -0.06%. Regarding short-term risk, CNMD is less volatile compared to LMRI. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check LMRI's competition here
Silk Road Medical, Inc (NASDAQ: SILK)
CNMD vs SILK Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas SILK's P/E ratio is -18.96. In terms of profitability, CNMD's ROE is +0.06%, compared to SILK's ROE of -0.35%. Regarding short-term risk, CNMD is more volatile compared to SILK. This indicates higher risk in terms of short-term price fluctuations for CNMD.Check SILK's competition here
IRadimed Corporation (NASDAQ: IRMD)
CNMD vs IRMD Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, IRMD has a market cap of 1.1B. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while IRMD trades at $86.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas IRMD's P/E ratio is 43.69. In terms of profitability, CNMD's ROE is +0.06%, compared to IRMD's ROE of +0.23%. Regarding short-term risk, CNMD is less volatile compared to IRMD. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check IRMD's competition here
Paragon 28, Inc. (NYSE: FNA)
CNMD vs FNA Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas FNA's P/E ratio is -19.83. In terms of profitability, CNMD's ROE is +0.06%, compared to FNA's ROE of -0.35%. Regarding short-term risk, CNMD is more volatile compared to FNA. This indicates higher risk in terms of short-term price fluctuations for CNMD.Check FNA's competition here
Bioventus Inc. (NASDAQ: BVS)
CNMD vs BVS Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, BVS has a market cap of 966.1M. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while BVS trades at $13.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas BVS's P/E ratio is 18.76. In terms of profitability, CNMD's ROE is +0.06%, compared to BVS's ROE of +0.28%. Regarding short-term risk, CNMD is less volatile compared to BVS. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check BVS's competition here
Anteris Technologies Global Corp. (NASDAQ: AVR)
CNMD vs AVR Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, AVR has a market cap of 914M. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while AVR trades at $9.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas AVR's P/E ratio is -4.22. In terms of profitability, CNMD's ROE is +0.06%, compared to AVR's ROE of -0.78%. Regarding short-term risk, CNMD is less volatile compared to AVR. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check AVR's competition here
CeriBell, Inc. (NASDAQ: CBLL)
CNMD vs CBLL Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, CBLL has a market cap of 885.2M. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while CBLL trades at $23.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas CBLL's P/E ratio is -14.31. In terms of profitability, CNMD's ROE is +0.06%, compared to CBLL's ROE of -0.45%. Regarding short-term risk, CNMD is less volatile compared to CBLL. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check CBLL's competition here
InMode Ltd. (NASDAQ: INMD)
CNMD vs INMD Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, INMD has a market cap of 870.8M. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while INMD trades at $15.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas INMD's P/E ratio is 10.52. In terms of profitability, CNMD's ROE is +0.06%, compared to INMD's ROE of +0.12%. Regarding short-term risk, CNMD is more volatile compared to INMD. This indicates higher risk in terms of short-term price fluctuations for CNMD.Check INMD's competition here
Cardiovascular Systems, Inc. (NASDAQ: CSII)
CNMD vs CSII Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, CSII has a market cap of 844M. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas CSII's P/E ratio is -20.83. In terms of profitability, CNMD's ROE is +0.06%, compared to CSII's ROE of -0.14%. Regarding short-term risk, CNMD is more volatile compared to CSII. This indicates higher risk in terms of short-term price fluctuations for CNMD.Check CSII's competition here
SI-BONE, Inc. (NASDAQ: SIBN)
CNMD vs SIBN Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, SIBN has a market cap of 839.5M. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while SIBN trades at $18.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas SIBN's P/E ratio is -55.68. In terms of profitability, CNMD's ROE is +0.06%, compared to SIBN's ROE of -0.08%. Regarding short-term risk, CNMD is less volatile compared to SIBN. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check SIBN's competition here
AdaptHealth Corp. (NASDAQ: AHCO)
CNMD vs AHCO Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, AHCO has a market cap of 790.5M. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while AHCO trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas AHCO's P/E ratio is 11.86. In terms of profitability, CNMD's ROE is +0.06%, compared to AHCO's ROE of -0.15%. Regarding short-term risk, CNMD is less volatile compared to AHCO. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check AHCO's competition here
Beta Bionics, Inc. (NASDAQ: BBNX)
CNMD vs BBNX Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, BBNX has a market cap of 790.5M. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while BBNX trades at $17.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas BBNX's P/E ratio is -11.64. In terms of profitability, CNMD's ROE is +0.06%, compared to BBNX's ROE of -0.26%. Regarding short-term risk, CNMD is less volatile compared to BBNX. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check BBNX's competition here
SS Innovations International, Inc. (NASDAQ: SSII)
CNMD vs SSII Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, SSII has a market cap of 778.5M. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while SSII trades at $3.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas SSII's P/E ratio is -75.87. In terms of profitability, CNMD's ROE is +0.06%, compared to SSII's ROE of -0.27%. Regarding short-term risk, CNMD is less volatile compared to SSII. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check SSII's competition here
Varex Imaging Corporation (NASDAQ: VREX)
CNMD vs VREX Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, VREX has a market cap of 778.4M. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while VREX trades at $18.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas VREX's P/E ratio is 19.46. In terms of profitability, CNMD's ROE is +0.06%, compared to VREX's ROE of +0.05%. Regarding short-term risk, CNMD is more volatile compared to VREX. This indicates higher risk in terms of short-term price fluctuations for CNMD.Check VREX's competition here
BrainsWay Ltd. (NASDAQ: BWAY)
CNMD vs BWAY Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, BWAY has a market cap of 640.1M. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while BWAY trades at $15.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas BWAY's P/E ratio is 41.46. In terms of profitability, CNMD's ROE is +0.06%, compared to BWAY's ROE of +0.12%. Regarding short-term risk, CNMD is less volatile compared to BWAY. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check BWAY's competition here
OrthoPediatrics Corp. (NASDAQ: KIDS)
CNMD vs KIDS Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, KIDS has a market cap of 637M. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while KIDS trades at $24.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas KIDS's P/E ratio is -21.02. In terms of profitability, CNMD's ROE is +0.06%, compared to KIDS's ROE of -0.12%. Regarding short-term risk, CNMD is less volatile compared to KIDS. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check KIDS's competition here
Cytek Biosciences, Inc. (NASDAQ: CTKB)
CNMD vs CTKB Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, CTKB has a market cap of 631.5M. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while CTKB trades at $4.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas CTKB's P/E ratio is -25.91. In terms of profitability, CNMD's ROE is +0.06%, compared to CTKB's ROE of -0.24%. Regarding short-term risk, CNMD is less volatile compared to CTKB. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check CTKB's competition here
Surmodics, Inc. (NASDAQ: SRDX)
CNMD vs SRDX Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while SRDX trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas SRDX's P/E ratio is -34.66. In terms of profitability, CNMD's ROE is +0.06%, compared to SRDX's ROE of -0.10%. Regarding short-term risk, CNMD is more volatile compared to SRDX. This indicates higher risk in terms of short-term price fluctuations for CNMD.Check SRDX's competition here
Cerus Corporation (NASDAQ: CERS)
CNMD vs CERS Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, CERS has a market cap of 600.5M. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while CERS trades at $2.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas CERS's P/E ratio is -59.48. In terms of profitability, CNMD's ROE is +0.06%, compared to CERS's ROE of -0.10%. Regarding short-term risk, CNMD is less volatile compared to CERS. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check CERS's competition here
Delcath Systems, Inc. (NASDAQ: DCTH)
CNMD vs DCTH Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, DCTH has a market cap of 599.3M. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while DCTH trades at $16.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas DCTH's P/E ratio is 1736.00. In terms of profitability, CNMD's ROE is +0.06%, compared to DCTH's ROE of +0.00%. Regarding short-term risk, CNMD is less volatile compared to DCTH. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check DCTH's competition here
Apollo Endosurgery, Inc. (NASDAQ: APEN)
CNMD vs APEN Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas APEN's P/E ratio is -9.43. In terms of profitability, CNMD's ROE is +0.06%, compared to APEN's ROE of -0.85%. Regarding short-term risk, CNMD is more volatile compared to APEN. This indicates higher risk in terms of short-term price fluctuations for CNMD.Check APEN's competition here
Tactile Systems Technology, Inc. (NASDAQ: TCMD)
CNMD vs TCMD Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, TCMD has a market cap of 545.9M. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while TCMD trades at $23.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas TCMD's P/E ratio is 27.50. In terms of profitability, CNMD's ROE is +0.06%, compared to TCMD's ROE of +0.11%. Regarding short-term risk, CNMD is less volatile compared to TCMD. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check TCMD's competition here
ZimVie Inc. (NASDAQ: ZIMV)
CNMD vs ZIMV Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while ZIMV trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, CNMD's ROE is +0.06%, compared to ZIMV's ROE of -0.01%. Regarding short-term risk, CNMD is more volatile compared to ZIMV. This indicates higher risk in terms of short-term price fluctuations for CNMD.Check ZIMV's competition here
NeuroPace, Inc. (NASDAQ: NPCE)
CNMD vs NPCE Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, NPCE has a market cap of 503.6M. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while NPCE trades at $14.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas NPCE's P/E ratio is -22.72. In terms of profitability, CNMD's ROE is +0.06%, compared to NPCE's ROE of -1.20%. Regarding short-term risk, CNMD is less volatile compared to NPCE. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check NPCE's competition here
ClearPoint Neuro, Inc. (NASDAQ: CLPT)
CNMD vs CLPT Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, CLPT has a market cap of 460M. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while CLPT trades at $15.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas CLPT's P/E ratio is -13.00. In terms of profitability, CNMD's ROE is +0.06%, compared to CLPT's ROE of -1.88%. Regarding short-term risk, CNMD is less volatile compared to CLPT. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check CLPT's competition here
Sight Sciences, Inc. (NASDAQ: SGHT)
CNMD vs SGHT Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, SGHT has a market cap of 442.9M. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while SGHT trades at $8.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas SGHT's P/E ratio is -14.54. In terms of profitability, CNMD's ROE is +0.06%, compared to SGHT's ROE of -0.51%. Regarding short-term risk, CNMD is less volatile compared to SGHT. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check SGHT's competition here
Orthofix Medical Inc. (NASDAQ: OFIX)
CNMD vs OFIX Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, OFIX has a market cap of 418M. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while OFIX trades at $10.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas OFIX's P/E ratio is -13.51. In terms of profitability, CNMD's ROE is +0.06%, compared to OFIX's ROE of -0.14%. Regarding short-term risk, CNMD is more volatile compared to OFIX. This indicates higher risk in terms of short-term price fluctuations for CNMD.Check OFIX's competition here
Carlsmed, Inc. (NASDAQ: CARL)
CNMD vs CARL Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, CARL has a market cap of 389.3M. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while CARL trades at $13.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas CARL's P/E ratio is -10.01. In terms of profitability, CNMD's ROE is +0.06%, compared to CARL's ROE of -0.38%. Regarding short-term risk, CNMD is less volatile compared to CARL. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check CARL's competition here
Perspective Therapeutics, Inc. (AMEX: CATX)
CNMD vs CATX Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, CATX has a market cap of 366.1M. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while CATX trades at $3.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas CATX's P/E ratio is -2.28. In terms of profitability, CNMD's ROE is +0.06%, compared to CATX's ROE of -0.42%. Regarding short-term risk, CNMD is less volatile compared to CATX. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check CATX's competition here
Pacific Biosciences of California, Inc. (NASDAQ: PACB)
CNMD vs PACB Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, PACB has a market cap of 357.2M. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while PACB trades at $1.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas PACB's P/E ratio is -2.80. In terms of profitability, CNMD's ROE is +0.06%, compared to PACB's ROE of -49.62%. Regarding short-term risk, CNMD is less volatile compared to PACB. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check PACB's competition here
Picard Medical, Inc. (AMEX: PMI)
CNMD vs PMI Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, PMI has a market cap of 353.3M. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while PMI trades at $3.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas PMI's P/E ratio is -2.87. In terms of profitability, CNMD's ROE is +0.06%, compared to PMI's ROE of +4.99%. Regarding short-term risk, CNMD is less volatile compared to PMI. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check PMI's competition here
Electromed, Inc. (AMEX: ELMD)
CNMD vs ELMD Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, ELMD has a market cap of 342.6M. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while ELMD trades at $40.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas ELMD's P/E ratio is 35.37. In terms of profitability, CNMD's ROE is +0.06%, compared to ELMD's ROE of +0.22%. Regarding short-term risk, CNMD is less volatile compared to ELMD. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check ELMD's competition here
CapsoVision, Inc. (NASDAQ: CV)
CNMD vs CV Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, CV has a market cap of 339.3M. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while CV trades at $6.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas CV's P/E ratio is -2.72. In terms of profitability, CNMD's ROE is +0.06%, compared to CV's ROE of -1.78%. Regarding short-term risk, CNMD is less volatile compared to CV. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check CV's competition here
Senseonics Holdings, Inc. (NASDAQ: SENS)
CNMD vs SENS Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, SENS has a market cap of 326.4M. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while SENS trades at $7.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas SENS's P/E ratio is -3.90. In terms of profitability, CNMD's ROE is +0.06%, compared to SENS's ROE of -1.66%. Regarding short-term risk, CNMD is less volatile compared to SENS. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check SENS's competition here
TriSalus Life Sciences, Inc. (NASDAQ: TLSI)
CNMD vs TLSI Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, TLSI has a market cap of 324.5M. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while TLSI trades at $5.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas TLSI's P/E ratio is -3.14. In terms of profitability, CNMD's ROE is +0.06%, compared to TLSI's ROE of +2.74%. Regarding short-term risk, CNMD is less volatile compared to TLSI. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check TLSI's competition here
Semler Scientific, Inc. (NASDAQ: SMLR)
CNMD vs SMLR Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while SMLR trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas SMLR's P/E ratio is 3.92. In terms of profitability, CNMD's ROE is +0.06%, compared to SMLR's ROE of +0.06%. Regarding short-term risk, CNMD is more volatile compared to SMLR. This indicates higher risk in terms of short-term price fluctuations for CNMD.Check SMLR's competition here
Treace Medical Concepts, Inc. (NASDAQ: TMCI)
CNMD vs TMCI Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, TMCI has a market cap of 310.7M. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while TMCI trades at $4.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas TMCI's P/E ratio is -5.10. In terms of profitability, CNMD's ROE is +0.06%, compared to TMCI's ROE of -0.74%. Regarding short-term risk, CNMD is less volatile compared to TMCI. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check TMCI's competition here
Anika Therapeutics, Inc. (NASDAQ: ANIK)
CNMD vs ANIK Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, ANIK has a market cap of 287.7M. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while ANIK trades at $21.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas ANIK's P/E ratio is 43.88. In terms of profitability, CNMD's ROE is +0.06%, compared to ANIK's ROE of -0.03%. Regarding short-term risk, CNMD is less volatile compared to ANIK. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check ANIK's competition here
RxSight, Inc. (NASDAQ: RXST)
CNMD vs RXST Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, RXST has a market cap of 285.2M. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while RXST trades at $6.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas RXST's P/E ratio is -7.41. In terms of profitability, CNMD's ROE is +0.06%, compared to RXST's ROE of -0.17%. Regarding short-term risk, CNMD is less volatile compared to RXST. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check RXST's competition here
Monogram Orthopaedics, Inc. (NASDAQ: MGRM)
CNMD vs MGRM Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while MGRM trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas MGRM's P/E ratio is -12.00. In terms of profitability, CNMD's ROE is +0.06%, compared to MGRM's ROE of -0.85%. Regarding short-term risk, CNMD is more volatile compared to MGRM. This indicates higher risk in terms of short-term price fluctuations for CNMD.Check MGRM's competition here
Profound Medical Corp. (NASDAQ: PROF)
CNMD vs PROF Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, PROF has a market cap of 240.9M. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while PROF trades at $6.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas PROF's P/E ratio is -5.35. In terms of profitability, CNMD's ROE is +0.06%, compared to PROF's ROE of -0.56%. Regarding short-term risk, CNMD is less volatile compared to PROF. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check PROF's competition here
Neuronetics, Inc. (NASDAQ: STIM)
CNMD vs STIM Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, STIM has a market cap of 229.6M. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while STIM trades at $3.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas STIM's P/E ratio is -6.11. In terms of profitability, CNMD's ROE is +0.06%, compared to STIM's ROE of -1.51%. Regarding short-term risk, CNMD is less volatile compared to STIM. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check STIM's competition here
Nevro Corp. (NYSE: NVRO)
CNMD vs NVRO Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas NVRO's P/E ratio is -1.91. In terms of profitability, CNMD's ROE is +0.06%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, CNMD is more volatile compared to NVRO. This indicates higher risk in terms of short-term price fluctuations for CNMD.Check NVRO's competition here
Avita Medical Inc. (NASDAQ: RCEL)
CNMD vs RCEL Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, RCEL has a market cap of 195M. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while RCEL trades at $7.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas RCEL's P/E ratio is -5.00. In terms of profitability, CNMD's ROE is +0.06%, compared to RCEL's ROE of +2.32%. Regarding short-term risk, CNMD is less volatile compared to RCEL. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check RCEL's competition here
BioSig Technologies, Inc. (NASDAQ: BSGM)
CNMD vs BSGM Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while BSGM trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas BSGM's P/E ratio is -5.81. In terms of profitability, CNMD's ROE is +0.06%, compared to BSGM's ROE of +15.26%. Regarding short-term risk, CNMD is less volatile compared to BSGM. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check BSGM's competition here
Lucid Diagnostics Inc. (NASDAQ: LUCD)
CNMD vs LUCD Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, LUCD has a market cap of 184.6M. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while LUCD trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas LUCD's P/E ratio is -2.62. In terms of profitability, CNMD's ROE is +0.06%, compared to LUCD's ROE of -4.04%. Regarding short-term risk, CNMD is less volatile compared to LUCD. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check LUCD's competition here
Xylo Technologies Ltd. (NASDAQ: MDGS)
CNMD vs MDGS Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while MDGS trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas MDGS's P/E ratio is -0.27. In terms of profitability, CNMD's ROE is +0.06%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, CNMD is less volatile compared to MDGS. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check MDGS's competition here
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL)
CNMD vs FOCL Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, FOCL has a market cap of 178.4M. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while FOCL trades at $4.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas FOCL's P/E ratio is -5.81. In terms of profitability, CNMD's ROE is +0.06%, compared to FOCL's ROE of -1.38%. Regarding short-term risk, CNMD is less volatile compared to FOCL. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check FOCL's competition here
Quipt Home Medical Corp. (NASDAQ: QIPT)
CNMD vs QIPT Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while QIPT trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas QIPT's P/E ratio is -15.87. In terms of profitability, CNMD's ROE is +0.06%, compared to QIPT's ROE of -0.10%. Regarding short-term risk, CNMD is more volatile compared to QIPT. This indicates higher risk in terms of short-term price fluctuations for CNMD.Check QIPT's competition here
Inogen, Inc. (NASDAQ: INGN)
CNMD vs INGN Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, INGN has a market cap of 155.7M. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while INGN trades at $5.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas INGN's P/E ratio is -6.32. In terms of profitability, CNMD's ROE is +0.06%, compared to INGN's ROE of -0.13%. Regarding short-term risk, CNMD is less volatile compared to INGN. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check INGN's competition here
Quanterix Corporation (NASDAQ: QTRX)
CNMD vs QTRX Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, QTRX has a market cap of 122M. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while QTRX trades at $2.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas QTRX's P/E ratio is -1.62. In terms of profitability, CNMD's ROE is +0.06%, compared to QTRX's ROE of -0.44%. Regarding short-term risk, CNMD is less volatile compared to QTRX. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check QTRX's competition here
Owlet, Inc. (NYSE: OWLT)
CNMD vs OWLT Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, OWLT has a market cap of 120.9M. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while OWLT trades at $6.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas OWLT's P/E ratio is -47.71. In terms of profitability, CNMD's ROE is +0.06%, compared to OWLT's ROE of -0.50%. Regarding short-term risk, CNMD is less volatile compared to OWLT. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check OWLT's competition here
iCAD, Inc. (NASDAQ: ICAD)
CNMD vs ICAD Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while ICAD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas ICAD's P/E ratio is -20.37. In terms of profitability, CNMD's ROE is +0.06%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, CNMD is more volatile compared to ICAD. This indicates higher risk in terms of short-term price fluctuations for CNMD.Check ICAD's competition here
Pulmonx Corporation (NASDAQ: LUNG)
CNMD vs LUNG Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, LUNG has a market cap of 102.2M. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while LUNG trades at $2.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas LUNG's P/E ratio is -1.86. In terms of profitability, CNMD's ROE is +0.06%, compared to LUNG's ROE of -0.97%. Regarding short-term risk, CNMD is less volatile compared to LUNG. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check LUNG's competition here
Solana Company (NASDAQ: HSDT)
CNMD vs HSDT Comparison August 2026
CONMED Corporation (NYSE: CNMD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNMD stands at 1.5B. In comparison, HSDT has a market cap of 101.6M. Regarding current trading prices, CNMD is priced at $49.29 on the NYSE, while HSDT trades at $1.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNMD currently has a P/E ratio of 11.09, whereas HSDT's P/E ratio is -0.02. In terms of profitability, CNMD's ROE is +0.06%, compared to HSDT's ROE of -1.55%. Regarding short-term risk, CNMD is less volatile compared to HSDT. This indicates lower risk in terms of short-term price fluctuations for CNMD.Check HSDT's competition here